Revolution in Diabetes Management
Eat With Confidence

Two slices of pizza and one beer

BG
92mg/dL
Carbs
83g
Target
115mg/dL
ISF
54
IOB
5.90
Suggested Bolus
7.70u
Prev Activity Next Activity
Lunch
Revolution in Diabetes Management
Exercise Without Worry

Let's get moving

BG
115 mg/dL
IOB
1.5 u
Suggested Snack
30g
Prev Activity Next Activity
Exercise
Revolution in Diabetes Management
Sleep Through The Night

We've got you covered

Uninterrupted sleep:
8 hours
Family disrupted:
None
Suggested pillow:
down
Prev Activity Next Activity
Restful Sleep
 

clinical trial hours since 2008

18 Patents
9 Clinical Sites
24 Clinical Trials
425 Patients
inControl Diabetes Management Platform

TypeZero is leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.

Learn about our intelligent systems

Our Products

From complex, day-to-day diabetes management to safe, simple, and effective control.

inControl<

inControl

Effectively managing your diabetes is a daily struggle – inControl is a smartphone-based, artificial pancreas solution that automatically controls insulin delivery, virtually eliminates hypoglycemia and dramatically improves blood glucose levels. inControl eliminates the need for minute-to-minute decision making, allowing you to spend less time managing your diabetes and more time living your life. TypeZero has designed this product to reduce the significant device burden associated with diabetes and to create a unified solution that can be configured to your preference and lifestyle.

inControl Advice<

inControl Advice

How you manage your diabetes is a very personal decision. There are so many choices about what devices to use or what strategies to implement. TypeZero understands that its technology needs to adapt to your treatment paradigm and how you live your life. inControl Advice is a mobile based advisory system that generates real-time recommendations for meals, basal rates, bolus calculations and exercise decisions. This application utilizes your CGM, pump or smart-pen to give you optimal advice, risk prediction and notifications which allows you to answer the question, “What should I do now?”.

inControl Cloud<

inControl Cloud

Your life is constantly evolving – TypeZero has built a cloud based analytics and support system that can provide the resources you need as life changes. inControl Cloud is a configurable set of tools designed to engage your support network in the management of your diabetes. This cloud based system provides real-time monitoring and notifications for caregivers and family as well as retrospective analysis on your data to identify areas of systemic risk or treatment inefficiencies. inControl Cloud is there to engage your family, support network and clinicians as your needs evolve.

Our Team

TypeZero is assembling a diverse and seasoned team of professionals with significant experience in diabetes technology research, Artificial Pancreas, medical devices, and start-up management. This team is dedicated to changing the way the world treats and manages diabetes.

  • headshot7

    Chad Rogers

    CEO
  • headshot

    Patrick Keith-Hynes

    CSO
  • IMG_0436

    Jamey Quinn

    VP of Engineering
  • ryan_derose

    Ryan DeRose

    VP of Product Development
  • headshot2

    Benton Mize

    Software Engineer
  • headshot3

    Antoine Robert

    Software Engineer
  • unnamed

    Molly McElwee-Malloy

    Patient Engagement
  • MLC headshot

    Meagan Collins

    Operations Manager
  • headshot6

    Boris Kovatchev

    Chief Mathematician
  • headshot4

    Marc Breton

    Algorithm Research
  • heatshot5

    Stephen Patek

    Algorithm Research

headshot7

Chad Rogers

CEO

Chad is a Founder and CEO of TypeZero. He is focused on the day to day strategy, operations, product vision and overall commercialization efforts for the company. Chad comes from a startup background in medical devices and software.

headshot

Patrick Keith-Hynes

CSO

As a TypeZero founder and CSO Patrick is focused on rapidly bringing the inControl system to market. Patrick developed the DiAs smartphone-based Artificial Pancreas system while an Assistant Research Professor at the University of Virginia.

IMG_0436

Jamey Quinn

VP of Engineering

As director of software engineering, Jamey leads TypeZero’s technology adoption, development operations, and product testability and execution efforts. He employs big data processes, statistical analysis, and behavior modeling to advance TypeZero’s software solutions.

ryan_derose

Ryan DeRose

VP of Product Development

Ryan leads TypeZero’s product development efforts. Founder of a local digital creative agency, Ryan brings an expertise in digital marketing, creative strategy, and design.

headshot2

Benton Mize

Software Engineer

Benton, T1D since 2005, has worked on this platform as it has progressed from UVA to the current version at TypeZero. He is passionate about device integration, ease of use, and reducing system complexity for fellow PWDs.

headshot3

Antoine Robert

Software Engineer

Antoine has been working on the UVA's artificial pancreas research platform since 2012. At TypeZero, he is now focused on the design and development of mobile applications and cloud-oriented solutions to support diabetes management.

unnamed

Molly McElwee-Malloy

Patient Engagement

Molly is the Head of Patient Engagement and Director of Marketing at TypeZero. She is focused on ensuring the patient is at the epicenter of TypeZero's mission. Molly has had T1D since 1998.

MLC headshot

Meagan Collins

Operations Manager

Meagan oversees TypeZero's day-to-day office operations and provides project management and communications support. Her background is in corporate communications, PR and medical education administration.

headshot6

Boris Kovatchev

Chief Mathematician

Boris is a Founder and the Chief Mathematician at TypeZero. He is the founder of UVA’s Center for Diabetes Technology and has spent the past 20 years of his career advancing the field of diabetes management through the invention of new models, algorithms and new closed loop technologies.

headshot4

Marc Breton

Algorithm Research

Marc, a TypeZero founder, is a Faculty of the UVa Schools of Medicine and Engineering. Co-founder of the UVA Artificial Pancreas Team (2006), Marc focuses on insulin dosing solutions and computer simulations for therapy optimization in Diabetes.

heatshot5

Stephen Patek

Algorithm Research

Steve, a TypeZero founder, is an Associate Professor of Systems and Information Engineering and has been part of the UVA Artificial Pancreas Team since 2007. Steve focuses on algorithm architecture, advice solutions, simulation and CGM analytics for therapy optimization.

In The News

Stay informed on the latest right here. We have compiled stories, press releases, blogs and news about TypeZero and the diabetes industry to keep the community informed on the progress and developments in the industry.

Want to get involved?

Send us a message. We love hearing from those involved in the diabetes community.

Contact Us